Adult Immunodeficiency Committee (AIC)
The AIC is dedicated to addressing the needs of Adults with IEI, focusing on understanding the current transition practices from pediatrics to adult care, and the natural history of many IEIs without transplant.
Advocacy Committee
The Advocacy Committee meets on an as-needed basis to develop the extent and the manner in which CIS pursues actions to influence government policy at the state and federal level.
Chair
Nicholas Hartog, MD
Members
George E. Freigeh, MD, MA
Joud Hajjar, MD, PhD, MS, FCIS
Ciang Sang Tan, MD
Joud Hajjar, MD, PhD, MS, FCIS
Edwin Dickerson, PhD, MSc, MBA
Yasmin W. Khan, MD
Niraj C. Patel, MD, MS
Michele N. Pham, MD
Nikita Raje, MD, MSc
Joyce E. Yu, MD
Serena B. Shaffren, MD
Continuing Medical Education (CME) Committee
The Continuing Medical Education (CME) Committee is responsible for review and oversight of CME activity planning, interaction with planners and speakers, content development and review, and the management of commercial support for all directly and jointly sponsored CME activities in addition to oversight of the ACCME re-accreditation process every four years. This committee meets approximately four times per year via conference call.
Chair
Manar Abdalgani, MD
Members
George E. Freigeh, MD, MA
Joud Hajjar, MD, PhD, MS, FCIS
Ciang Sang Tan, MD -
Diagnostic Laboratory Immunology (DLI) Committee
The mission of the Diagnostic Laboratory Immunology Committee will be to create, promote and curate all matters relevant to DLI in its contribution to the overall mission of the CIS (to facilitate education, translational research and novel approaches to therapy in clinical immunology to promote excellence in the care of patients with immunologic/inflammatory disorders).
Chair
James Verbsky, MD, PhD, FCIS
Members
Jordan Abbott, MD
Neema Izadi, MD, MS
Stanley J. Naides, MD
Xiao P. Peng, MD, PhD
Megan S. Piazza, PhD
Teresa K. Tarrant, MD
Russell H. Tomar, MD
Diversity & Inclusion (D&I) Committee
The purpose of this committee is to promote and enhance diversity, equity, and inclusion within the Clinical Immunology Society and within the broader fields of Clinical, Translational, and Investigational Immunology. The committee will focus on education, advocacy, mentorship and other efforts to expand the diversity of voices and opinions within our vibrant and exciting field. This will build on the successes and groundwork laid by the Women in Clinical Immunology Society (WCIS) committee and WCIS will become a standing subcommittee within the Diversity and Inclusion Committee. The Committee will encourage and help facilitate diversity within CIS leadership, committee membership, speakers at webinars and educational activities, and annual meeting sessions. Additionally, the Committee will provide input to the CIS Executive Council regarding diversity and inclusion in the CIS Strategic Plan and will work with the Council to carry out these elements of the Plan.
Co-Chairs
Hey J. Chong, MD PhD
Blachy Javier Davila-Saldana, MD - Children's National Medical Center
Members
Manar Abdalgani, MD
George E. Freigeh, MD, MA
Vivian P. Hernandez-Trujillo, MD
Michael D. Keller, MD, FCIS
Gabriel Mendoza
Aisha Mohammed
David W. Rosenthal, DO, PhD
Jacqueline D. Squire, MD
Sneha Suresh, MD
WCIS is a subcommittee within the Diversity and Inclusion Committee. The goal of the WCIS Committee is to support and encourage the advancement of women at all levels (general members, students, residents, fellows, post-doctoral, clinicians, and faculty) in the CIS to attain their full academic potential via mentorship, sponsorship, personal and professional development, leadership, innovation, inclusiveness, and a welcoming and supportive climate.
Chair
Joud Hajjar, MD, PhD, MS, FCIS
Members
Hanadys Ale, MD
Sara Barmettler, MD
Diana K. Bayer, DO
Monica A. Fernandes
Alexandra F. Freeman, MD, FCIS
Catherine Freeman
Jessica Galant-Swafford
Melissa D. Gans, MD
Lauren M. Gunderman, MD
Vivian P. Hernandez-Trujillo, MD
Vy Kim, MD, MScCH, FRCPC, FCIS
Ashley T. Nguyen, MD
Megan Piazza, PhD, FACMG
Nikita Raje, MD MSc
Madeline M. Schutt, MD
Jessica A. Willett Pachul, RN, MN, CPedN(C)
Early Career Immunologists (ECI) Committee
The Early Career Immunologists (ECI) Committee is responsible for developing and overseeing benefits and programs for current and future Trainee Members and junior faculty members. The ECI Committee will meet regularly via conference call and will work with other committees such as the Education, Program, and Membership Committees throughout the year to assist with CIS communications and Annual Meeting planning targeted to Trainee Members and junior faculty members as well as membership recruitment.
Co-Chairs
Carolyn H. Baloh, MD - Brigham & Women's Hospital
Natalia S. Chaimowitz, MD, PhD - Cook Children's Hospital
Members
Hanadys Ale, MD
Dharmagat Bhattarai, MBBS, MD, DM, FESID
Timothy M. Buckey
Maria Chitty Lopez, MD
Jessica R. Durkee-Shock
Jessica Galant-Swafford
Lauren M. Gunderman, MD
Anna Lang, MD, PhD
Joao Pedro Matias Lopes
John McDonnell, MD
Whitney Reid, MD
Jason Eric Schend, DO
Erica G. Schmitt, MD, PhD
Benjamin D. Solomon, MD, PhD
Monica Tang
Juanita Valdes Camacho, MD
The FIT Subcommitee is focused on generating a community of peers to discuss clinical cases, research efforts, and career development. As a subcommittee of ECI, FIT members can better acess mentorship from those in Early Carreer immunology.
Education Committee
The Education Committee will work to develop and implement educational activities that would be of interest to members including, but not limited to, webinars, podcasts, videos, and various live activities. The committee will also provide members with current information on available educational opportunities within the society, and initiate and implement educational policies.
Chair
Karin Chen, MD, FCIS
Members
Carol T. Cady, MD PhD, FCIS
Jason W. Caldwell, DO
Shanmuganathan Chandrakasan, MD, FCIS
Saara Kaviany, DO
Harry Layton Lesmana, MD
Ali Sobh, MD, FAAAAI
Nicolai S. Van Oers
Yesim Yilmaz Demirdag, MD
Fellows of the CIS (FCIS) Committee
The purpose of the CIS Fellowship Committee is to serve as an oversight body to review the eligibility of applicants seeking the FCIS designation. Current Fellows maintaining the FCIS designation in good standing will recommend future Fellows. This committee is not for the fellows-in-training. For a full description of the FCIS designation, visit the membership page.
Co-Chairs
John M. Routes, MD, FCIS
Members
Roshini Sarah Abraham, PhD, D(ABMLI), FCIS
Karin Chen, MD, FCIS
Megan A. Cooper, MD PhD, FCIS
Sudhir Gupta, MD PhD MACP FAAAAI, FCIS
Joud Hajjar, MD, PhD, MS, FCIS
Monica G. Lawrence, MD, FCIS
Neil Romberg, MD, FCIS
Troy R. Torgerson, MD PhD, FCIS
Foundation Committee
The CIS Foundation Committee was created to support the CIS Foundation with its fundraising which will advance research and education among CIS members and the larger patient and donor community. Learn more about the CIS Foundation.
Chair
Kelli W. Williams, MD, MPH, FCIS
Members
Lisa R. Forbes Satter, MD
Alexandra F. Freeman, MD, FCIS
Niraj C. Patel, MD, MS
Troy R. Torgerson, MD, PhD, FCIS
Investigators of CIS (I-CIS) Committee
The Investigators of CIS Committee works to build a community of basic, translational and clinical investigators to advance the discovery and treatment of inborn errors of immunity. They do so by providing a framework for educational programming and activities specific to the needs of investigators and advocating for funding and other support for the career development of clinical immunology investigators.
Co-Chairs
Megan A. Cooper, MD, PhD, FCIS
Lisa R. Forbes Satter, MD
Members
Manish J. Butte, MD PhD, FCIS
Scott Canna
Helene Decaluwe, MD, PhD, FRCPC, FCIS
Alexandra F. Freeman, MD, FCIS
Joud Hajjar, MD, PhD, MS, FCIS
Elena WY Hsieh, MD, FCIS
Michael B. Jordan, MD, FCIS
Stuart G. Tangye, PhD, FCIS, FAHMS
Beth K. Thielen, MD, PhD
Stuart Turvey, MBBS, DPhil, FRCPC, FCIS
Alice Chan, MD, PhD, FCIS
Shanmuganathan Chandrakasan, MD, FCIS
Ivan K. Chinn, MD, FCIS
Monica A. Fernandes
Elie Haddad, MD PhD, FCIS
Sarah E. Henrickson, M.D., Ph.D., FCIS
Avni Y. Joshi, MD, MS, FCIS
Matthew Kan, MD, PhD
Aaruni Khanolkar
Jennifer Leiding, MD, FCIS
Stanley J. Naides, MD
Nikita Raje, MD MSc
Teresa K. Tarrant, MD
Kelli W. Williams, MD, MPH, FCIS
Membership Committee
The Membership Committee shall review the applications for eligibility on the basis of criteria approved by the Council including good moral and ethical character. The Membership Committee meets to approve members and discuss business approximately four to six times a year.
Chair
Jordan Abbott, MD
Members
Aisha Ahmed, MD
Carol T. Cady, MD PhD, FCIS
Magda MS Carneiro-Sampaio, MD, PhD, FCIS
Katherine L. Tuttle, MD
Program Committee (2025 Annual Meeting)
The Program Committee develops the programming and abstract selection for the Annual Meeting, along with fundraising efforts and may be asked to moderate interactive discussions generated from the presentations. The committee meets via conference call approximately six times during the program development.
Co-Chairs
Manish J. Butte, MD PhD, FCIS
Megan A. Cooper, MD PhD, FCIS
Elie Haddad, MD PhD, FCIS
Members
Aisha Ahmed, MD
Aristoteles Alvarez-Cardona, MD MSc.
Catherine Biggs
Nicholas L. Hartog, MD
Jennifer Heimall, MD, FCIS
Sarah E. Henrickson, M.D., Ph.D., FCIS
Caroline Kuo, MD
Jennifer Leiding, MD, FCIS
Michail S. Lionakis, FCIS
Craig D. Platt, MD, PhD, FCIS
Andrew L. Snow, PhD, FCIS
Tiphanie Vogel, MD PhD
Klaus Warnatz
Thymic Defect Taskforce (TDT)
The Thymic Defect Taskforce's (TDT) mission is to address the growing need in the field of Clinical Immunology and Primary Immunodeficiencies of the role of thymus transplantation in the management of patients with thymic defects. The objectives of the taskforce would be to develop guidelines, on behalf of CIS that would outline the biology of thymic defects, the gaps in clinical care, current management strategies, need and access issues in thymus transplantation, protocols of thymus transplantation and monitoring, regulatory issues and future directions. The TDT will also endeavor to collaborate with existing registries to expand an existing, or add a new registry for patients diagnosed with thymic defects, especially via newborn screening.
Chair
Elie Haddad, MD, PhD
Members
Luigi D. Notarangelo, MD, FCIS
Troy R. Torgerson, MD, PhD, FCIS
Jack J. Bleesing, MD, PhD, FCIS
Rebecca A. Marsh, MD, FCIS
Cathleen Collins, MD, PhD
Michael D. Keller, MD, FCIS
Vivian P. Hernandez-Trujillo, MD
Ivan K. Chinn, MD, FCIS
E. Graham Davies
M. Teresa De La Morena, MD, FCIS
Michail S. Lionakis, MD
Peter Mustillo, MD
Marita Bosticardo, PhD
Prescott Atkinson, MD, PhD, FAAAAI
Elisa Ochfeld, MD
Daniel C. Adelman, MD, FCIS
Alexandra Y. Kreins